Newly identified mutations that contribute to a higher susceptibility of idiopathic pulmonary arterial hypertension (IPAH) in people…
Articles by Steve Bryson, PhD
Genetic screening of patients with persistent pulmonary hypertension of the newborn (PPHN) found…
Orenitram (treprostinil tablets) reduced clinical worsening and slowed disease progression in people with pulmonary arterial hypertension (PAH) who…
Infants with mild or severe forms of persistent pulmonary hypertension of the newborn,…
Analysis of a North American pediatric registry revealed significant variability of pulmonary hypertension (PH) subtypes among children of…
V-Wave’s new interatrial shunt — a medical device designed to reduce arterial heart pressure…
The U.S. Food and Drug Administration (FDA) has granted orphan drug status to…
Only two non-invasive diagnostic tests are required to best predict the risk of adverse events in people with…
Disrupting the vascular remodeling feedback signaling loop mediated by CD146-HIF-1α can effectively prevent the development of…
Blocking the protein interleukin-1 (IL-1) protects against pulmonary hypertension (PH) induced by complications…